Antibiotice, the most important manufacturer of generic medicines with Romanian capital, announced its financial results for last year. Total revenues amounted to 640.73 million RON, 10 percent higher compared to the planned value (580.5 million RON). Compared to the value achieved in 2022, they are 23 percent higher.
Total expenses amounted to 549.55 million RON, 3 percent higher compared to the planned value (530.49 million RON) and by 14 percent higher compared to the value achieved in 2022 (480.32 million RON).
Gross profit amounted to 91.18 million RON, higher than the planned level (50 million RON) and higher than the value recorded in 2022 (41.9 million RON).
Net profit amounted to 80.7 million RON, higher than the planned level (42 million RON) and than the value recorded in 2022 (38.5 million RON).
In 2023, the value of medicines released to the patiens from Romania was 29.96 billion RON, higher by 16.2 percent compared to 2022. Consumption of medicines increased by 2.4 percent in 2023, a number of 722.6 million boxes being released from the pharmacies.
Of the total pharmaceutical market in Romania, 44.5 percent (in terms of value) is represented by the segment of generics, prescription and non-prescription medicines. In the analyzed period, the generics market registered a 14.0 percent value increase, from 11.7 billion RON to 13.3 billion RON. In terms of quantity, it increased by 1.4 percent, with a number of 530 million boxes released from pharmacies in 2023 compared to 522.7 million boxes in 2022.
Prescription drugs (RX) represented 43.4 percent of total value sales in 2023 and 48.9 percent of total generic drug consumption (reported as number of boxes). These recorded a 18.3 percent increase in value, from 4.9 billion RON in 2022 to 5.8 billion RON in 2023 and a 4.8 percent increase in terms of quantity, from 247.1 to 259.1 million boxes in 2023.
Non-prescription drugs (non-RX) recorded a 10 percent value increase (from 6.8 billion RON to 7.5 billion RON in 2023) and dropped by 1.7 percent in terms of quantity, from 275.6 million boxes in 2022 to 271.0 million boxes in 2023.
By market segments, the sales situation in the market developed as follows:
– hospital – the sales increased by 13.3 percent, from 1.03 billion RON in 2022 to 1.16 billion RON in 2023. In the analyzed period, consumption increased by 9.4 percent from 22.8 to 25,0 million boxes;
– national pharmacy chains – the sales increased by 11.0 percent, from 4.23 billion RON in 2022 to 4.69 billion RON in 2023. In terms of quantity, a slight decline of 0.7 percent was recorded compared to 2022, from 196.8 million boxes in 2022 to 195.3 million boxes in 2023;
– independent pharmacies and minichains – the sales increased by 16.1 percent, from 6.43 billion RON in 2022 to 7.46 billion RON in 2023. In terms of quantity, a 2.2 percent increase was recorded in 2023 compared to 2022, from 303.2 to 309.8 million boxes.
